Twist Bioscience (TWST) Depreciation & Amortization (CF) (2017 - 2026)

Twist Bioscience has disclosed Depreciation & Amortization (CF) across 10 years of filings, most recently posting $6.4 million for Q1 2026.

• In Q1 2026, Depreciation & Amortization (CF) changed 0.19% year-over-year to $6.4 million; the TTM figure through Mar 2026 stood at $24.7 million (down 11.04% YoY), while the FY2025 annual figure was $24.9 million, down 20.93% from the prior year.
• Depreciation & Amortization (CF) advanced to $6.4 million in Q1 2026, from $6.2 million in the prior quarter.
• Over the last five years, Depreciation & Amortization (CF) for TWST reached as high as $8.5 million in Q3 2023 and fell as low as $4.0 million in Q1 2022.
• The 5-year median for Depreciation & Amortization (CF) is $6.4 million (2025), against an average of $6.6 million.
• Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) soared 103.7% — and 2025, when it fell 26.94%.
• A 5-year view of Depreciation & Amortization (CF) shows it stood at $5.3 million in 2022, then soared by 54.4% to $8.2 million in 2023, then dropped by 21.92% to $6.4 million in 2024, then slipped by 2.92% to $6.2 million in 2025, then climbed by 3.55% to $6.4 million in 2026.
• According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $6.4 million, $6.2 million, and $6.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.